Condition

Amyloid

ClinicalTrials.gov condition label

Clinical trials20
Recruiting4
Common interventions21
Lead sponsors shown13

Clinical trials

20 shown
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)NCT07589595 · 2026-05-20
RECRUITING
[18F]FT8 PET Imaging in Immunoglobulin Light Chain AmyloidosisNCT07232459 · 2025-07-21
RECRUITING
Pan-Amyloid PET/CT in Various Amyloid-Related DiseaseNCT07130565 · 2023-11-01
RECRUITING
Beta Amyloid PET/CT in Various Aβ-Related DiseaseNCT06725706 · 2012-09-01
RECRUITING
A Study of LY4560736 in Healthy Participants and Participants With Alzheimer's Disease (AD)NCT07843459 · 2026-10-01
NOT_YET_RECRUITING
A Study of LY4405094 in Healthy Participants and Participants With Alzheimer's DiseaseNCT07787182 · 2026-09-01
NOT_YET_RECRUITING
A Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and Participants With Alzheimer's DiseaseNCT07787169 · 2026-09-01
NOT_YET_RECRUITING
Fractional CO₂ Laser for Primary Cutaneous AmyloidosisNCT07815132 · 2024-09-10
COMPLETED
Amyloidosis Incidence in High-Risk Cardiac Device PatientsNCT06186167 · 2024-01-29
UNKNOWN
18F-florbetaben PET-CT to Non-invasively Diagnose Cardiac AL AmyloidosisNCT06048601 · 2023-01-26
UNKNOWN
Time-in-bed Restriction in Older Adults With Sleep Difficulties With and Without Risk for Alzheimer's DiseaseNCT05138848 · 2022-01-03
COMPLETED
Selinexor for Treatment of Light Chain Amyloidosis With Relapsed/Refractory DiseaseNCT04984330 · 2021-12-01
WITHDRAWN
Transdermal Trigeminal Electrical Neuromodulation on Mild Cognitive Impairment With InsomniaNCT05200897 · 2021-11-03
UNKNOWN
Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to DaratumumabNCT04270175 · 2021-04-14
ACTIVE_NOT_RECRUITING
Amyloid Proteins From Medullary Thyroid Cancer and Laryngeal AmyloidosisNCT04760171 · 2021-02-01
UNKNOWN
Atrial Amyloid May Influence Outcomes in Patients Undergoing Surgical Aortic Valve ReplacementNCT07105501 · 2020-11-03
COMPLETED
Detection of Amyloid Deposits in the Wrist by MRI With Mapping and High Resolution Sequences in Systemic Amyloidosis (AMYLOCARP)NCT05150353 · 2020-01-24
COMPLETED
Screening for Systemic Amyloidosis Via the Ligamentum FlavumNCT03923920 · 2019-05-01
COMPLETED
Monitoring of Early Disease Progression in Hereditary Transthyretin AmyloidosisNCT03431896 · 2018-02-01
COMPLETED
Platelet Reactivity, B-amyloid, MOTS-c and Mortality of Type II Diabetics With CADNCT04027712 · 2014-01-01
UNKNOWN

Common interventions

PlaceboDRUG4Florbetaben F 18OTHER3Florbetapir F18OTHER3DexamethasoneDRUG2LY4405094DRUG2[18F]FT8DIAGNOSTIC_TEST118F-92/AV45, 11C-PIBDIAGNOSTIC_TEST118F-92/AV45/TPZA/FT8, 11CPIBDIAGNOSTIC_TEST118F-florbetaben PET/CTDIAGNOSTIC_TEST1BiopsyPROCEDURE1Chest Wall Fat Tissue CollectionPROCEDURE1Daratumumab SCDRUG1DonanemabDRUG1Fractional CO₂ LaserDEVICE1LY4560736DRUG1MRIPROCEDURE1PomalidomideDRUG1SelinexorDRUG1Sleep ScheduleBEHAVIORAL1Time in Bed RestrictionBEHAVIORAL1Transdermal trigeminal electrical neuromodulation(Cefaly)DEVICE1

Trial status mix

COMPLETED6
UNKNOWN5
RECRUITING4
NOT_YET_RECRUITING3
ACTIVE_NOT_RECRUITING1
WITHDRAWN1

Phase mix

NA4
PHASE13
EARLY_PHASE12
PHASE22

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.